En | De
No articles selected!     View Cart  
You are here: Psychiatry » Schizophrenia and Psychotic Disorders 30. October 2020
Schizophrenia and Psychotic Disorders
Advanced search
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Anxiety Disorders
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2688  Previews Next
   Articles 1 - 20 / 53754  
Adaptation of a Digital Health Innovation to Prevent Relapse and Support Recovery in Youth Receiving Services for First-Episode Psychosis: Results From the Horyzons-Canada Phase 1 Study.
JMIR Form Res
Lal S, Gleeson J, Rivard L, D'Alfonso S, Joober R, Malla A, Alvarez-Jimenez M.
PMID: 33118945 [PubMed - as supplied by publisher]

Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study.
Integr Pharm Res Pract
Bahta M, Berhe T, Russom M, Tesfamariam EH, Ogbaghebriel A.
PMID: 33117667 [PubMed]

Classification of Schizophrenia by Functional Connectivity Strength Using Functional Near Infrared Spectroscopy.
Front Neuroinform
Yang J, Ji X, Quan W, Liu Y, Wei B, Wu T.
PMID: 33117140 [PubMed]

Application of SWATH mass spectrometry in the identification of circulating proteins does not predict future weight gain in early psychosis.
Clin Proteomics
Heald A, Azadbakht N, Geary B, Conen S, Fachim H, Lee DCH, Geifman N, Farman S, Howes O, Whetton A, Deakin B.
PMID: 33117088 [PubMed]

Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study.
Neuropsychiatr Dis Treat
Inada K, Yamada S, Akiyoshi H, Kojima Y, Iwashita S, Ishigooka J.
PMID: 33116525 [PubMed]

Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder.
Am J Psychiatry
Glausier JR, Enwright JF 3rd, Lewis DA.
PMID: 33115248 [PubMed - as supplied by publisher]

Strength training restores force-generating capacity in patients with schizophrenia.
Scand J Med Sci Sports
Nygård M, Brobakken MF, Taylor JL, Reitan SK, Güzey IC, Morken G, Lydersen S, Vedul-Kjelsås E, Wang E, Heggelund J.
PMID: 33113211 [PubMed - as supplied by publisher]

Classification of schizophrenia using general linear model and support vector machine via fNIRS.
Phys Eng Sci Med
Chen L, Li Q, Song H, Gao R, Yang J, Dong W, Dang W.
PMID: 33113110 [PubMed - as supplied by publisher]

Cognitive reserve in patients with first-episode psychosis as outcome predictor at 5-year follow-up.
Eur Child Adolesc Psychiatry
Camprodon-Boadas P, de la Serna E, Baeza I, Puig O, Ilzarbe D, Sugranyes G, Borras R, Castro-Fornieles J.
PMID: 33113026 [PubMed - as supplied by publisher]

One-year aerobic interval training in outpatients with schizophrenia: A randomized controlled trial.
Scand J Med Sci Sports
Brobakken MF, Nygård M, Güzey IC, Morken G, Reitan SK, Heggelund J, Vedul-Kjelsaas E, Wang E.
PMID: 33108030 [PubMed - as supplied by publisher]

Neurophysiological Face Processing Deficits in Patients With Chronic Schizophrenia: An MEG Study.
Front Psychiatry
Ohara N, Hirano Y, Oribe N, Tamura S, Nakamura I, Hirano S, Tsuchimoto R, Ueno T, Togao O, Hiwatashi A, Nakao T, Onitsuka T.
PMID: 33101080 [PubMed]

Speech Prosody as a Bridge Between Psychopathology and Linguistics: The Case of the Schizophrenia Spectrum.
Front Psychiatry
Lucarini V, Grice M, Cangemi F, Zimmermann JT, Marchesi C, Vogeley K, Tonna M.
PMID: 33101074 [PubMed]

The Role of Zebrafish and Laboratory Rodents in Schizophrenia Research.
Front Psychiatry
Langova V, Vales K, Horka P, Horacek J.
PMID: 33101067 [PubMed]

Association between the COMT Val158Met polymorphism and antipsychotic efficacy in schizophrenia: an updated meta-analysis.
Curr Neuropharmacol
Ma J, Zhao M, Zhou W, Li M, Huai C, Shen L, Wang T, Wu H, Zhang N, Zhang Z, He L, Qin S.
PMID: 33100205 [PubMed - as supplied by publisher]

Cannabis and non-psychotic mental disorders.
Curr Opin Psychol
Patten SB.
PMID: 33099271 [PubMed - as supplied by publisher]

Gesture deficits and apraxia in schizophrenia.
Walther S, Mittal VA, Stegmayer K, Bohlhalter S.
PMID: 33099076 [PubMed - as supplied by publisher]

A randomised controlled trial of metacognitive training for psychosis, depression, and belief flexibility.
J Affect Disord
Ho-Wai So S, Hoi-Kei Chan G, Kit-Wa Wong C, Wing-Ka Ching E, Sze-Wai Lee S, Chi-Wing Wong B, Zhu C, Sun X, Kin-Hei Chung L, Hung AY, Oi-Yin Wong J, Sau-Man Chan S.
PMID: 33099054 [PubMed - as supplied by publisher]

Gut Microbiome in Schizophrenia: Altered Functional Pathways Related to Immune Modulation and Atherosclerotic Risk.
Brain Behav Immun
Nguyen TT, Kosciolek T, Daly RE, Vázquez-Baeza Y, Swafford A, Knight R, Jeste DV.
PMID: 33098964 [PubMed - as supplied by publisher]

Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study.
Neurol Ther
Patel PJ, Weidenfeller C, Jones AP, Nilsson J, Hsu J.
PMID: 33098548 [PubMed - as supplied by publisher]

Overlapping Neurobiological Substrates for Early-Life Stress and Resilience to Psychosis.
Biol Psychiatry Cogn Neurosci Neuroimaging
DeRosse P, Barber AD.
PMID: 33097471 [PubMed - as supplied by publisher]

   Articles 1 - 20 / 53754    Page 1 of 2688  Previews Next

Rect Bottom
Adserver Footer





Forgot your username or password?


New User? Sign Up

Register to My Medline!


Learn more about the My Medline experience

more >>

  Time frame  

Sky right 1